This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: C2 Diagnostics. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovations by Jérôme Giraud in Blood Sample Analysis
Introduction
Jérôme Giraud is an accomplished inventor based in Montpellier, France. He has made significant contributions to the field of medical diagnostics, particularly in the analysis of blood samples. His innovative approach has led to the development of a patented method that enhances the efficiency and accuracy of blood analysis.
Latest Patents
Jérôme Giraud holds a patent for a "Method for the analysis of a blood sample, and apparatus and reagent for its implementation." This method involves the automatic analysis of a blood sample using an analysis solution that includes the blood sample, a diluent, and compounds to lyze erythrocytes. The process allows for the measurement of hemoglobin levels through spectrophotometry after the lysis of erythrocytes. Additionally, the analysis solution contains compounds to protect leukocytes, enabling the differentiation of at least four main leukocyte sub-populations. This innovative method is supported by a haematological analysis apparatus designed for its implementation.
Career Highlights
Jérôme Giraud is associated with C2 Diagnostics, where he continues to advance his research and development efforts. His work focuses on improving diagnostic techniques that can lead to better patient outcomes. With a single patent to his name, he has already made a notable impact in the medical field.
Collaborations
Jérôme collaborates with Henri Champseix, contributing to the development of innovative solutions in blood analysis. Their partnership exemplifies the importance of teamwork in advancing medical technology.
Conclusion
Jérôme Giraud's contributions to blood sample analysis through his patented method demonstrate his commitment to innovation in medical diagnostics. His work at C2 Diagnostics and collaboration with Henri Champseix highlight the potential for advancements in healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
